The serum response transcription factor (Srf) controls developmental programs and proliferation, differentiation, cellular shape and cytoskeleton organization. Its activity is regulated through the mitogen-activated protein kinase pathway (MAPK)/ Erk pathway and the GTPases Rho/mDia/actin pathway, allowing integration of extracellular mitogenic signals with changes in actin cytoskeleton. The Srf co-activators myocardinrelated transcription factors (Mrtfs) assist Srf in the expression of genes linked to actin cytoskeleton dynamics. Among Mrtfs, the megakaryocytic acute leukemia (MAL) (also known as Mrtf-A and megakaryoblastic leukemia-1) is an actin-binding protein whose nuclear accumulation is controlled by the actin treadmilling cycle. 1, 2 The human MAL gene is fused to the OTT/ RBM15 gene in acute megakaryoblastic leukemia (AMKL) 3, 4 and a contribution of Mal activity to the late steps of murine and human megakaryopoiesis has been reported. 5, 6 Although the lack of Srf results in major cellular defects and embryonic lethality (reviewed in Miano et al. 7 ), Mal germ line deficiency results in a limited myoepithelial cells phenotype 8, 9 probably because of the redundancies of Mrtf proteins.
To gain insight into the role of Srf and Mal in megakaryocyte (Mk) development, we compared the defects induced by their lossof-function in adult hematopoietic cells. Srf flx mice 10 were bred with polyinosine-polycytidine-inducible Mx1-Cre mice, 11 then analyzed 5 weeks post-induction (Supplementary Figure 1) . The Mal/Mrft-A À/À mice have been reported. 9 Null animals showed thrombocytopenia with 72 and 25% of wild-type average platelet counts for Mal À/À and Srf D/D; MxÀCre respectively ( Figure 1a) . In vivo, Mal-and Srf-null platelet half-life was similar to control, indicating that the thrombocytopenia was not the result of an accelerated clearance (Supplementary Figure 2) . In spite of the thrombocytopenia, immunochemical (Figure 1b ) and flow cytometric ( Figure 1c ) analyses showed accumulation of bone marrow (BM) Mks in null animals. Srf and Mal were dispensable for the control of ploidy (Supplementary Figure 3) . However, both mutant cells showed a diminished capacity to form proplatelet (PP) structures in culture medium, with less than half of them showing short cytoplasmic extensions resembling PPs, when compared with normal counterparts (Figure 1d ). Transmission electron microscopy revealed major alterations in Srf-null Mks morphology with cytoplasmic fragments scattered throughout the BM space and naked nuclei, suggesting that Mks had fragmented in situ (Figure 2iv ). No platelets were observed, further underscoring an abnormal fragmentation within the marrow. Circulating platelets had an altered morphology with an increase in mean platelet volume of around 30% (Figure 1a ) and the macrothrombocytopenia was confirmed by ultra-structure (Figure 2viii ). Morphology of Mal-null Mks was less altered. A majority of them were extremely mature, with well-developed demarcation membranes and randomly scattered -granules, and showed some cytoplasmic extensions with a thin outer ring of cytoplasm suggesting that they were beginning to form PPs in the marrow; very few showed a smooth surface (Figure 2ii ). In agreement, numerous deposits of von Willebrand factor (vWF) immunostaining were scattered in BM space, indicating that local platelet production had occurred ( Figure 1b) . Mal À/À platelets were associated with an elongated shape and less -granules than their wild-type counterparts We analyzed by quantitative reverse transcriptase-PCR (RT-PCR), the expression levels of several Srf target genes and genes linked to the formation of cytoskeletal structures (Figure 3 ). Tropomyosin 1 (Tpm1), Actin B (Actb) and Filamin A (Flna) genes, which participate in the organization of Mk and platelet actin cytoskeleton, were markedly under expressed in the two null genotypes, indicating a contribution of the Srf/Mal complex to their expression. A low expression of the matrix metallopeptidase 9 (Mmp9) and myosin light chain 9 (Myl9)/Mlc2 genes, known as MAL/SRF targets 5, 12 was observed. The abnormal 
Po0.05 by Mann-Whitney test).
Letters to the Editor shape and irregular aspect of Srf-null Mk evoke the cytoskeleton abnormalities observed in the myosin heavy chain 9 (Myh9)-deficient mice 13 and in human patients affected by MYH9-related disorders, and indeed, transcript levels of Myh9 were diminished, although to a lesser extent. Myosin is an important structural component of Mks, PPs and platelets cytoskeleton. Impairment of its activity may alter the structure (demarcation membrane and cytoplasm 14 ), maturation 15, 16 and function of Mk; it may also affect the intracellular cytoskeleton tensions that control Mk morphology. In line, the drosophila MAL-D/SRF complex regulates cell tension and is required for a robust actin cytoskeleton during cell migration. 17 A contribution of MMP9 activity in the stromal-derived factor 1-induced migration of human Mks has been reported. 5, 18 Taken together, changes in actin dynamics or in the expression of cell motility effectors (Tpm1, Mmp9, Myl9) may profoundly affect the migration of Mks and/or of their progenitors in the BM, leading to their accumulation in situ and defective platelets release in the bloodstream.
Although the human MAL gene is specifically involved in the pathogenesis of a pediatric AMKL through its involvement in the t(1;22)(p13;q13) chromosomic translocation, Mal ablation does not affect on most primitive hematopoietic cells development, nor on MEP, CMP and GMP compartments (Supplementary Figure 4) . This contrasts with the severe phenotypes that frequently afflict hematopoietic stem cells and/or their progenitors on invalidation of leukemia-associated transcriptional regulators. 19 In addition, the Mk-restricted defects observed in Mal-deficient adult hematopoiesis contrast with the dramatic effects observed in adult animals on Srf inactivation (Ragu et al. submitted). These discrepancies could be explained by functional redundancies between Mrtf factors in the other hematopoietic cells and/or by the presence of a functional ternary complex factor/Srf pathway activated by the MAPK/Erk signalling, in Mal-null animals.
In conclusion, our results show a major contribution of the Srf/Mal network in Mk development. Both null genotypes showed a thrombocytopenia associated with an expansion of progenitors and mature Mks in BM. They also showed a decreased proportion of Mks extending PPs and a downregulation of genes associated with cytoskeleton dynamics (Tpm1, Actb, Flna) and cellular motility (Myl9, Mmp9), indicating that Srf/Mal-mediated transcriptional regulation contributes to the formation and maintenance of the actomyosin cytoskeleton required for Mks migration and platelet biogenesis. Defects in actin cytoskeleton dynamics linked to Mk differentiation/maturation and functions, suggest a specific role for MAL in the association between the t(1;22)(p13;q13) translocation and AMKL. À cells of wild-type and mutant mice of the two genotypes were cultured in a serum-free media containing 10 ng/ml thrombopoietin and mature Mks were enriched by the bovine serum albumin velocity sedimentation method. Relative expression of candidate genes was measured by quantitative RT-PCR. No significant difference was observed between samples in mRNA contents for the Talin, Integrin b 1 (Itgb1) and Tropomyosin 2 (Tpm2) candidate genes. This may rule out a predominant role of Srf or Mal in their transcriptional regulation in Mks, in contrast to other cell types. 7, 20 Expression level of Kindlin-3, which is abundantly expressed in Mks and platelets, was also unaffected. Expression levels were normalized to Gapdh and results were expressed relative to the level of each gene in wild-type Mks (set to 1) (n ¼ 3 per genotype). The histogram shows means of two experiments, each in triplicate.
